CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities:
Net income	$ 1,864	$ 1,990
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	376	370
Provision for loan losses	350	454
Amortization of purchase accounting adjustments	0	(17)
Net amortization of securities	331	230
Gain on sale of securities, net	(106)	(80)
Gain on sale of fixed assets, net	(23)	0
Gain on sale of other real estate owned, net	(5)	(1)
FHLB stock dividend	(18)	(11)
Stock-based compensation	179	141
Deferred taxes	(141)	(228)
Net change in value of bank owned life insurance	(47)	(42)
Loans held for sale:
Originations	0	(495)
Proceeds from sales	0	23,837
Gain on sale of loans	0	(313)
Net change in:
Accrued interest receivable	(25)	(148)
Other assets	125	927
Accrued taxes and other liabilities	6,272	807
Net cash provided by operating activities	9,132	27,421
Cash flows from investing activities:
Proceeds from sales of investment securities available for sale	10,325	3,440
Funds invested in securities available for sale	(26,577)	(19,594)
Proceeds from maturities, prepayments and calls of investment securities available for sale	5,944	2,111
Proceeds from maturities, prepayments and calls of investment securities held to maturity	421	143
Purchase of other equity securities	(940)	(1,338)
Net increase in loans	(8,881)	(45,779)
Proceeds from sales of other real estate owned	25	62
Proceeds from the sales of fixed assets	291	0
Purchases of fixed assets	(346)	(489)
Acquisition of trademark intangible	0	(100)
Purchase of bank owned life insurance	0	(3,500)
Net cash used in investing activities	(19,738)	(65,044)
Cash flows from financing activities:
Net (decrease) increase in customer deposits	(39,233)	71,317
Net decrease in repurchase agreements	(2,726)	(9,422)
Net decrease in short-term FHLB advances	(5,000)	(21,903)
Proceeds from long-term FHLB advances	5,000	0
Repayment of long-term FHLB advances	(390)	(1,633)
Proceeds from other borrowings	78	0
Repayment of other borrowings	(1,000)	0
Proceeds from subordinated notes, net of issuance costs	18,133	0
Cash dividends paid on common stock	(87)	(63)
Proceeds from public offering of common stock, net of issuance costs	32,553	0
Proceeds from stock options and warrants exercised	473	0
Payments to repurchase common stock	0	(315)
Net cash provided by financing activities	7,801	37,981
Net (decrease) increase in cash and cash equivalents	(2,805)	358
Cash and cash equivalents, beginning of period	29,448	20,966
Cash and cash equivalents, end of period	$ 26,643	$ 21,324